STOCK TITAN

Archimedes Tech SPAC Partners II Co. SEC Filings

ATIIU Nasdaq

Welcome to our dedicated page for Archimedes Tech SPAC Partners II Co. SEC filings (Ticker: ATIIU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The SEC filings page for Archimedes Tech SPAC Partners II Co. (ATIIU) is intended to provide access to the company’s regulatory documents once they are available through the U.S. Securities and Exchange Commission. Archimedes Tech SPAC Partners II Co. is described as a newly organized special purpose acquisition company and blank check company formed as a Cayman Islands exempted company, with units listed on The Nasdaq Global Market under the symbol ATIIU.

In its public announcements, the company notes that registration statements relating to its securities were declared effective by the SEC in connection with its initial public offering of units. While specific forms are not detailed in the provided information, SPACs typically file registration statements and related documents as part of their listing and offering process. These materials explain the structure of the units, the terms of the ordinary shares and redeemable warrants, and the general corporate purpose of the SPAC.

On Stock Titan, this filings page is designed to surface Archimedes Tech SPAC Partners II Co.’s SEC documents as they appear on the EDGAR system. Users can review registration statements and other filings to understand the company’s capital structure, the rights associated with its units, and the conditions under which the ordinary shares and warrants trade separately under the expected symbols ATII and ATIIW.

AI-powered tools on the platform can help interpret lengthy or technical filings by highlighting key sections, summarizing the structure of the offering, and clarifying the roles of the underwriter and other parties described in the documents. As additional filings become available, this page will serve as a centralized location to explore Archimedes Tech SPAC Partners II Co.’s regulatory history in connection with its status as a SPAC and shell company.

Rhea-AI Summary

Barclays PLC filed an amended Schedule 13G to report its beneficial ownership in Archimedes Tech SPAC Partner common stock. Barclays reports beneficial ownership of 1,148,590 common shares, representing 3.88% of the outstanding class as of the reported date.

Barclays states it has sole voting and sole dispositive power over all 1,148,590 shares, with no shared voting or dispositive power. The filing confirms that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Barclays PLC reports beneficial ownership of 1,864,405 shares of Archimedes Tech SPAC Partner common stock, representing 6.30% of the class. The filing shows Barclays has sole voting and dispositive power over 1,864,400 shares and shared voting and dispositive power over 5 shares, indicating control over the vast majority of its disclosed stake.

Barclays is classified as an HC (parent holding company) and identifies Barclays Bank PLC and Barclays Capital Securities Ltd as the subsidiaries that acquired the securities. The filing includes a certification that the shares were acquired and are held in the ordinary course of business and not to change or influence control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Archimedes Tech SPAC Partners II Co. is a blank-check company that completed its IPO on February 12, 2025, selling 23,000,000 Units (including a full 3,000,000-unit over-allotment) at $10.00 per Unit for gross proceeds of $230,000,000 and a simultaneous private placement of 840,000 Units for $8,400,000.

As of June 30, 2025 the company reports total assets of $236,897,701, comprised of $234,944,821 held in a Trust Account and $1,764,859 of cash outside the trust. Total liabilities are $8,209,120, including a deferred underwriting fee payable of $8,050,000. Ordinary shares subject to possible redemption (23,000,000 shares) are reflected at a redemption value of $234,944,821, producing shareholders' deficit of $(6,256,240).

The company had net income of $2.36 million for the quarter and $3.52 million for the six months ended June 30, 2025, driven by interest earned on trust assets of $2.49 million and $3.79 million, respectively, offset by general and administrative expenses of $130,359 and $277,020. The Company has not commenced operations, has not selected a Business Combination target, and must complete a Business Combination within the 21-month completion window or effect liquidation as described in its charter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report

FAQ

What is the current stock price of Archimedes Tech SPAC Partners II Co. (ATIIU)?

The current stock price of Archimedes Tech SPAC Partners II Co. (ATIIU) is $10.93 as of January 30, 2026.

What is the market cap of Archimedes Tech SPAC Partners II Co. (ATIIU)?

The market cap of Archimedes Tech SPAC Partners II Co. (ATIIU) is approximately 265.6M.
Archimedes Tech SPAC Partners II Co.

Nasdaq:ATIIU

ATIIU Rankings

ATIIU Stock Data

265.64M
20.77M
8.8%
Shell Companies
Blank Checks
United States
CLAYMONT

ATIIU RSS Feed